pfizer glp-1 drug Danuglipron: An Oral GLP-1R Agonist Competing with Peptide Injectables for Diabetes and Obesity 💊 The next trillion-dollar drug

This landmark policy change recognises obesity as a chronic disease and recommends that GLP-1 antagonists are used by adults for the long-term treatment of obesity

Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are two gut hormones, defined incretins, responsible for the amplification of insulin secretion after oral glucose intake

Turn ordinary foods into functional superfoods with GLP-1 Daily Support, a 4-in-1 prebiotic blend that naturally aids appetite control, blood sugar balance, and metabolic health

A smarter approach to appetite and metabolism

Only one of those is GLP-1

Working with George Karavetsos, former director of FDA's Office of Criminal...